SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending after a Cornell University study highlighted its APU's comparable performance to NVIDIA GPUs with significantly lower energy consumption, sparking discussions around AI market disruption and potential acquisitions. Community members are focused on the potential for significant energy savings in data centers and speculation about partnerships or buyouts from larger players like NVDA. The stock is gaining attention as a potential disruptor in the AI and edge computing space due to its energy efficiency.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors react to the company's potential expansion into rare earth minerals, viewing it as a strategic pivot amid discussions of a partnership with a major global steel producer. The community is actively debating the implications of this move, with some seeing it as a game-changer for U.S. strategic metals, while others express skepticism based on the CEO's past performance. Option traders are showing increased interest in the stock, indicating potential for significant price movement.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

KODK is trending as investors discuss the company's potential meme stock status, closing of a pension transfer, and possible short squeeze. Community talking points include the potential for significant returns once Kodak executes its pharma plans and secures new contracts. Some investors are awaiting confirmation of the Q3 earnings date and discussing Kodak's potential as a play in the reshoring of strategic industries.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending due to recent price volatility and analyst target price adjustments, sparking debate among investors about its valuation and future potential. Community discussions revolve around the impact of China tariffs, the Rhode acquisition, and upcoming earnings, with some viewing the dip as a buying opportunity while others anticipate further correction. Positive sentiment remains due to strong sales at Sephora and the brand's growth prospects, despite concerns over short-term headwinds.

Zoracles

Zoracles (ZORA) is trending as the community discusses its potential, noting a pattern of overnight pumps and daytime sell-offs. Some investors are optimistic about its long-term prospects, viewing it as a unique project with potential for significant growth. Others express frustration with its price action and await news or catalysts for a sustained breakout.

Storing value in digital art. Project launched by famous Korean artist with 144k instagram followers and millions of interactions. Created a token behind his digital art character ‘CUTIE’. The crypto community on X decided to support the artist by sharing his work to wider audiences. The artist is affiliated with some renowned names that have established and successful projects in the crypto space such as the artist behind $nub the silly nub cat.

Cute Style

$CUTIE is trending as a 'cute' crypto on the Phantom Wallet, experiencing significant community buzz and perceived momentum. While some users express enthusiasm and call for others to 'buy now,' others are cautioning about potential risks, including top holders concentration and possible liquidity issues. The community discussion revolves around its potential as a 'moon' shot and a 'Phantom Wallet gem.'

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending due to a widespread AWS outage impacting major websites and applications, sparking community discussion around the company's infrastructure and reliability. Some are pointing to the outage as evidence of Amazon's critical role in the internet ecosystem, while others anticipate potential lawsuits and a negative impact on upcoming earnings. There's also chatter about increased interest in decentralized solutions and alternative cloud providers.

AlphaVest Acquisition Corp. is a blank check company, which engages in effecting a merger, stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded on January 14, 2022 and is headquartered in New York, NY.

AlphaVest Acquisition Corp

AlphaVest Acquisition Corp ($ATMV) is trending due to a reported surge in after-hours trading possibly driven by merger news and PIPE financing. The community is discussing its low float, potential for a short squeeze, and speculating on price movements, with some mentioning a possible merger with AMC Corporation. Watchlists are highlighting key support and breakout levels.

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Danaher Corp.

Danaher ($DHR) is trending as investors react to unusual options activity, upcoming earnings, and analyst ratings. Community chatter highlights both bullish and bearish sentiment, with some eyeing potential entry points while others focus on concerns around cost headwinds. Upcoming earnings are a key catalyst, with analysts and investors watching for insights into the balance of performance across DHR's core segments.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as analysts are highlighting strong iPhone 17 sales and a potential multi-year growth cycle, leading to price target upgrades and renewed bullish sentiment. The community is actively discussing potential new all-time highs and whether to hold long-term or take profits. Additionally, Apple's expansion into sports streaming with a Formula 1 deal is sparking interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Investors Undervaluing Humana (HUM) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Beam Therapeutics (BEAM) Stock Outpacing Its Medical Peers This Year?

Here is how Beam Therapeutics Inc. (BEAM) and Humana (HUM) have performed compared to their sector so far this year.

Humana (HUM) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for Humana (HUM), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Humana (HUM) has reportedly lost a lawsuit seeking to undo cuts to the bonus payments it receives from the federal Medicare insurance program.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-14/humana-loses-second-lawsuit-to-reverse-medicare-bonus-cuts">reported</a> on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage. The judge had <a href="https://stocktwits.com/news-articles/markets/equity/humana-loses-lawsuit-over-medicare-bonus-cuts-stock-slides/ch8ks9QR5q8">dismissed</a> a similar case in July as well.Humana depends more than any other large insurer on revenue from the Medicare Advantage program, Bloomberg noted. About $3 billion was at stake in the lawsuit, the report said, citing consulting firm Capstone.Centers for Medicare &amp; Medicaid Services (CMS) assigns quality ratings, called stars, to Medicare Advantage plans, ranging from one to five, with five being the highest rating. Beneficiaries can use this data to help choose plans, and insurance companies can receive government bonus payments for higher ratings.Humana’s stock dropped as much as 4% at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HUM">HUM stock</a> stayed within the ‘bearish’ territory, coupled with ‘low’ message volume.<figure class="image"><img style="aspect-ratio:588/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_14_at_12_53_12_PM_png_e17a866cd8.webp" alt="HUM's Sentiment Meter and Message Volume as of 12:53 p.m. ET on Oct. 14, 2025 | Source: Stocktwits" width="588" height="62"><figcaption>HUM's Sentiment Meter and Message Volume as of 12:53 p.m. ET on Oct. 14, 2025 | Source: Stocktwits</figcaption></figure>Earlier this month, Humana <a href="https://stocktwits.com/news-articles/markets/equity/humana-stock-rises-after-insurer-reaffirms-full-year-earnings-guidance/chCrmVZR3fE">affirmed</a> its full-year earnings per share guidance provided in July.The insurer stated that it expects adjusted earnings per common share of $17 for the year ending Dec. 31, 2025, and diluted earnings per share of $13.77.The firm also stated that its preliminary 2026 Medicare Advantage (MA) Star Ratings align with the assumptions in its financial planning. As a result, there is no change to the incremental earnings potential for 2025 to 2028. The ratings data provided by the Centers for Medicare &amp; Medicaid Services was inadvertently accessible on CMS Plan Finder for a brief period on Oct. 1, 2025, the company stated.Humana has about 20% of its members currently enrolled in Medicare plans rated four stars and above for 2026, and 14% of members in 4.5-star plans for 2026, it said.“Based on all information available to date, the company remains confident in its 2026 Individual MA pricing and benefit design, including the expectation that it will double individual MA pre-tax margin in 2026 (excluding Stars), and believes it is positioned to return to membership growth in 2026,” the firm said.HUM stock rose 3% this year and fell about 2% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novavax-major-shareholder-calls-for-sale-of-company-to-larger-pharma-entity/ch6moRsR3mh">Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The MyHumana app page is displayed on a smartphone in the Apple App Store in front of the Humana Inc logo on October 30, 2024 in Chongqing, China. (Photo by Cheng Xin/Getty Images)

Humana Stock Slumps After Reportedly Losing Lawsuit Seeking To Undo Cuts To Medicare Bonus Payments

Bloomberg reported on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage.

Equity

Bloomberg reported on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage.


Humana Foundation Expands National Efforts to Improve Seniors Emotional Health

The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced its ambition to become a national leader in addressing seniors emotional health. More...

CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock?

CVS' Aetna shines in 2026 Medicare Star Ratings, with more than 81% of members in four-star plans, fueling a 73.5% YTD stock surge and strong investor momentum.

Humana Inc. to Release Third Quarter 2025 Results on November 5, 2025

Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2025 (3Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 5, 2025...

Mizuho Securities raised price targets on several large U.S. health insurers following the release of the latest Medicare Advantage star ratings, noting improved visibility into earnings.Analyst Ann Hynes raised her target on CVS Health to $88 from $76, UnitedHealth to $430 from $300, Elevance Health to $420 from $342 and Humana to $345 from $300 and maintained an 'Outperform' rating on all four stocks. The firm also lifted Centene’s target to $40 from $28 with a 'Neutral' rating.Hynes said the target changes were driven by a broader rotation into the healthcare sector after the U.S. government released its 2026 quality ratings for Medicare Advantage and prescription drug plans, which help determine bonus payments to insurers.Barclays also raised its price targets in the group, lifting UnitedHealth’s to $386 from $352 and Elevance Health’s to $395 from $373, both with Overweight ratings. The firm said Medicare remains the most stable business line, Medicaid the most uncertain, and Affordable Care Act exchanges are improving both “fundamentally and from a policy perspective.”CVS Health’s Aetna unit led with over 81% of members in top-rated programs, followed by UnitedHealth at 78%, Elevance at 55%, and Humana at 20%, according to federal data and company disclosures.In all, 64% of Medicare Advantage members with drug coverage are signed up for plans that get four or five stars, Oppenheimer said. The Centers for Medicare &amp; Medicaid Services rates plans on metrics including patient satisfaction, and performance on cancer screenings and management of chronic conditions, among others, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/litigation/cvs-says-over-81-members-are-high-rated-medicare-advantage-plans-2026-2025-10-09/">report</a>.Four and five-star plans receive bigger government payments that could add up to billions of dollars and have a financial impact in 2027, Oppenheimer said. The research firm added that results broadly matched expectations following company pre-announcements.&nbsp;Elevance showed one of the largest year-over-year gains, with 55% of its membership now in plans rated four stars or higher, up from 40% a year ago, while CVS said 63% of Aetna members are in 4.5-star plans. UnitedHealth said 40% of its members are in 4.5-star plans, and Humana reported 1.2 million members in highly rated offerings.Centene’s Wellcare CEO Michael Carson said the company was encouraged by progress in its star ratings.On Stocktwits, retail sentiment was ‘bullish’ for CVS Health amid ‘normal’ message volume, while sentiment for UnitedHealth, Elevance Health, Humana, and Centene was ‘bearish’ with ‘low’ message volume.So far this year, CVS Health shares are up 77%, while Humana has gained 16%. In contrast, UnitedHealth is down 26%, Elevance Health has slipped 2%, and Centene has dropped 38%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the United States Medicare logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

CVS, UnitedHealth, Elevance, Humana Gain Price Target Hikes On Wall Street After Medicare Star Ratings Update

Barclays raised targets on UnitedHealth and Elevance, saying Medicare remains the most stable business line, Medicaid the most uncertain, and Affordable Care Act exchanges are improving both fundamentally and from a policy standpoint.

Can Digital Workflows at Optum Rx Transform UNH's Patient Experience?

UnitedHealth drives a digital overhaul at Optum Rx, automating pharmacy workflows to boost efficiency and enrich patient care.

CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions

CVS company, Aetna, expands its Aetna Clinical Collaboration program to 10 hospitals, aiming to cut readmissions and ease hospital workloads.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$284.00
Prev Close	$275.01
Open	$275.65
Dividend Yield	1.40%
50-Day Moving Average	$280.10
Beta	0.32
Avg. Volume	2.07M
PE Ratio	21.80

52-Week High	$315.35
52-Week Low	$206.87
Market Capitalization	$34.16B
EPS (Annual)	$9.99
Price to Book	1.87
Revenue Per Employee	$1.79M
Enterprise Value/EBITDA	N/A

HUM
Humana Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HUM News

HUMHumana Inc